Clinical Trials Browser

Hyperthermia, Anus Neoplasms, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Fever, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Neuroendocrine Tumors

NCT06014944 2023-08-31

PMMR/MSS

Phase 2 Not yet recruiting

30 enrolled

Gastrointestinal

Rectal Neoplasms

NCT05969847 2023-08-01

TRACE-LE

Phase 2 Not yet recruiting

72 enrolled

Gastrointestinal

Rectal Neoplasms

NCT05807984 2023-04-11

Re-irradiation Therapy of Locally Recurrent Rectal Cancer With Carbon Ion

Phase 2 Not yet recruiting

31 enrolled

Gastrointestinal

Rectal Neoplasms, Recurrence

NCT05507112 2022-09-21

TIMENT-R

Phase 2 Not yet recruiting

100 enrolled

Gastrointestinal

Rectal Neoplasms

NCT04838496 2021-04-09

MEND-IT

Phase 2 Not yet recruiting

128 enrolled

Gastrointestinal

Rectal Neoplasms

NCT04443543 2020-06-30

An Adaptive-design Prospective Cohort Study of Watch and Wait Strategy in Patients With Locally Advanced Rectal Cancer

Phase 2 Not yet recruiting

222 enrolled

Gastrointestinal

Rectal Neoplasms

Clinical Trials

NEST3

Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer

Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer

Improvement Effect of Dexamethasone Enema for Acute Radiation-induced Rectal Injury

A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer

Neoadjuvant Moderately Hypofractionated Radiotherapy Combined With Chemotherapy and Immunotherapy for High-risk pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Multi-center Randomized Control Phase II Trial

ART-Hypo

Neoadjuvant Short-course Radiotherapy Followed by a Combination of Disitamab Vedotin, Sintilimab, and Capecitabine in Locally Advanced HER2-expressing Rectal Cance

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

A Phase II Prospective Study of Maastro Applicator Brachytherapy for Rectal Cancer

PKUCH- R11

Neoadjuvant mFOLFOX6 Chemotherapy Combined With Anti-PD-1 Therapy in MSS/pMMR Locally Advanced Rectal Cancer (FIRM02 Study)

ULTIMATE

Preventive Efficacy of Bergmann Enema for Acute Radiation-induced Rectal Injury in Rectal Cancer Patients Undergoing Short-course Radiotherapy

SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer

BCMRECRAD

QL1706 With Short-Course Radiotherapy and Chemotherapy for MSS Rectal Cancer

REFIRT

STAR

PET/MRI in Rectal Cancer

A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer

SCRIPBOT

TRACER

CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC

CGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRC

iMHRT-LARC

Organ Preservation With Tislelizumab and Total Neoadjuvant Therapy in Patients With Low Rectal Cancer: RELIEVE -01 Study

Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer

Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab

HETERERO

PMMR/MSS

TRACE-LE

Re-irradiation Therapy of Locally Recurrent Rectal Cancer With Carbon Ion

TIMENT-R

MEND-IT

An Adaptive-design Prospective Cohort Study of Watch and Wait Strategy in Patients With Locally Advanced Rectal Cancer